Jump to content

Acquired Resistance to Targeted Therapies in Lung Cancer – H


Recommended Posts

Acquired Resistance to Targeted Therapies in Lung Cancer – How Do the Experts Approach It?

March 8th, 2013 - by Dr. Jack West

http://expertblog.lungevity.org/2013/03 ... proach-it/

Here are a couple of great videos from several experts in lung cancer that describe their approach to the setting of acquired resistance, when a patient with a specific “targetable” mutation who responds well to the relevant treatment in question then develops progression of disease. This is actually a pretty new challenge in lung cancer, and most experts feel that there’s reason to consider some newer approaches.

Click on the link above to view the video links.

Dr. Greg Riely (Memorial Sloan-Kettering): How Should We Approach Acquired Resistance to Targeted Therapies in Advanced NSCLC?

Dr. Ravi Salgia (University of Chicago) on Management Strategies for Acquired Resistance to Targeted Therapies, Single Focus or More Diffuse

Dr. Geoffrey Oxnard on Managing Acquired Resistance to EGFR Inhibitor Therapy (and Probably Crizotinib, Too)

I’ll add a post in the next few days that includes the answers of several experts to the question of what they think are the most promising new targeted therapies for lung cancer that we might actually see integrated as treatment options for patients in the next few years.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.